Establishment of a population pharmacokinetic model to estimate valproic acid clearance in psychiatric patients
碩士 === 慈濟大學 === 藥理暨毒理學研究所 === 94 === Background: Valproic acid (VPA; valproate) is a drug that has been widely used as an anticonvulsant since the 1970s. VPA is currently approved by the FDA (USA) for the treatment of absence seizures, mixed seizures, and bipolar I disorder, manic phase. The efficac...
Main Authors: | Hui-Ching Huang, 黃輝慶 |
---|---|
Other Authors: | Ying-Lung Tseng |
Format: | Others |
Language: | en_US |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/89873898457134153004 |
Similar Items
-
Population Pharmacokinetics of Valproic Acid in Epileptic Patients at Prasat Neurological Institute
by: Weenarat Senawin, et al.
Published: (2014-08-01) -
Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
by: Lee SY, et al.
Published: (2015-08-01) -
Effects of Huangqin-Tang on pharmacokinetics of phenytoin and valproic acid
by: Jung-Chun Kao, et al.
Published: (2008) -
Pharmacokinetics of two monounsaturated metabolites of valproic acid in the rat
by: Singh, Kuldeep
Published: (2010) -
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.
by: Hiroo Nakashima, et al.
Published: (2015-01-01)